L26/P-027 Single-cell transcriptomic analysis of seminal round cells reveals distinct signatures across non-obstructive azoospermia phenotypes
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.363 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von I. Higueras Serrano und 12 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Can deep characterisation of seminal cell transcriptomes from non-obstructive azoospermia (NOA) patients reveal phenotype-specific differences and identify signatures predicting testicular sperm extraction (TESE) outcome? Summary answer Distinct cellular composition and transcriptomic signatures were identified across NOA subtypes, TESE outcome, and human leukocyte antigen (HLA) risk allele carriers. What is known already NOA represents the most severe form of male infertility. Its histological subtypes include hypospermatogenesis (HS), maturation arrest (MA) and Sertoli cell-only syndrome (SCO). Increasing evidence suggest that SCO has an immune-mediated nature, and it is usually associated with unsuccessful TESE (TESE-). Given that seminal fluid reflects both local and systemic immune activity, profiling seminal immune cell transcriptomes is essential for identifying SCO-associated inflammatory signatures, which would facilitate the development of predictive tools for TESE outcomes. However, the gene expression of seminal round cells has not yet been characterised at single-cell resolution. Study design, size, duration Seminal samples from azoospermic patients were collected and classified according to NOA subtype and TESE outcome. Genotypic data for each patient were also obtained, and targeted imputation of the HLA region was performed. Transcriptomic profiles of seminal cells were generated using single-cell RNA sequencing (scRNA-seq) technology, cell type identities were established, and differences in cellular composition and gene expression were compared according to NOA subtype, TESE outcome, and SCO-associated HLA-DRB1 risk-allele carrier status. Participants/materials, setting, methods Patients were classified accordingly with NOA subtype (6 HS, 4 MA, and 6 SCO) and TESE outcome (9 unsuccessful and 7 successful). Seminal-cell populations were isolated and scRNA-seq libraries were generated using the 10x Genomics Next GEM platform. After quality control and filtering, 35,646 cells were retained for cell-identity annotation, differential gene expression and pathway enrichment analyses, as well as for assessing differences in cellular composition across clinical classifications. Main results and the role of chance Seminal scRNA-seq profiling revealed a heterogeneous cellular landscape comprising germ, immune, and non-immune somatic populations. Within the immune compartment, myeloid cells (macrophages, monocytes, and dendritic cells) predominated, together with lymphoid subsets including B cells, CD4+ and CD8+ T cells, NK cells, and NKT cells, consistent with a complex seminal immune microenvironment. Among non-immune somatic cells, prostatic stem and differentiated epithelial cells were identified, whereas germ cells were scarce. Overall seminal-cell composition differed significantly according to TESE outcome (PERMANOVA p = 2.65E-02), with TESE- samples showing higher proportions of macrophages and monocytes, and TESE+ samples enriched for prostatic, epithelial, and germ cells. Differential expression and pathway analyses revealed a shared inflammatory signature in TESE-, SCO, and HLA-DRB1*13 carrier patients. In TESE- CD4+ T cells, differentially expressed genes were enriched for IL-17 signalling, Th17 and Th1/Th2 differentiation and antigen-processing and presentation pathways, CD8+ T cells were enriched for IL-17 signalling, and dendritic cells were enriched for antigen-processing and presentation, Th1/Th2 and Th17 differentiation pathways. SCO cells displayed a similar profile. Notably, HLA-DRB1*13 carriers, but not carriers of other HLA-DRB1 alleles, showed significant upregulation of genes involved in antigen-processing and presentation pathways. Limitations, reasons for caution Although scRNA-seq is a powerful approach to characterise and analyse gene expression profiles across seminal-cell populations, analysing a larger number of cells is needed to confirm our findings. Such validation is crucial for developing robust diagnostic tools to predict TESE success in NOA patients. Wider implications of the findings Despite its potential for biomarker discovery in NOA, seminal fluid remains poorly characterised at the cellular level. Profiling seminal-cell populations could identify diagnostic biomarkers and enable the development of predictive tools for TESE outcomes, ultimately reducing the need for unnecessary invasive procedures in NOA patients. Trial registration number No
Zitieren
APA
Serrano, I. H., Muñoz, S. G., Jiménez, A. G., Fernández, A. R., Zayas, M. M., Molina, M., Gonzalvo, M., Clavero, A., Castilla, J., Burgos, M., Morales, R. P., Castillo, L. B., & Carmona, F. (2026). L26/P-027 Single-cell transcriptomic analysis of seminal round cells reveals distinct signatures across non-obstructive azoospermia phenotypes. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.363
Vancouver
Serrano IH, Muñoz SG, Jiménez AG, Fernández AR, Zayas MM, Molina M, et al. L26/P-027 Single-cell transcriptomic analysis of seminal round cells reveals distinct signatures across non-obstructive azoospermia phenotypes. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.363
BibTeX
@article{Serrano2026,
author = {Serrano, I. Higueras and Muñoz, S. González and Jiménez, A. Guzmán and Fernández, A. Robles and Zayas, M. Molina and Molina, M. and Gonzalvo, M.C. and Clavero, A. and Castilla, J.A. and Burgos, M. and Morales, R.J. Palomino and Castillo, L. Bossini and Carmona, F.D.},
title = {L26/P-027 Single-cell transcriptomic analysis of seminal round cells reveals distinct signatures across non-obstructive azoospermia phenotypes},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.363}
}
EUVIMED